Impact of BRCA1 testing on women with cancer: a pilot study.

We sought to understand better the impact of genetic testing and counseling in a group of women who had early breast cancer (age <50) or ovarian cancer and a family history of cancer. Thirty-five women underwent genetic counseling and genetic testing for BRCA1/2 at the University of Colorado Cancer Center, Hereditary Cancer Clinic. Psychological assessment (IES and Hopkins Symptom Checklist) was made before counseling, and 1 month after genetic test results were reported to women. A statistically significant decrease in anxiety was evidenced 1 month after results were given (p = 0.024). Decreased intrusive thoughts related to genetic testing were seen only for those testing negative (p = 0.0003). Women diagnosed with cancer less than 1 year prior to genetic testing experienced the greatest cancer-specific distress (p = 0.01) and distress related to genetic testing (p = not significant). Satisfaction with the counseling and testing process was high. In conclusion, genetic testing and counseling can occur with little anxiety and stress. However, women less than 1 year from a cancer diagnosis will experience the greatest distress associated with genetic testing and counseling. Women who are considering genetic testing and counseling close to a diagnosis of cancer may require greater psychological support.

[1]  P Borgen,et al.  Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations. , 1999, Journal of the National Cancer Institute.

[2]  O. Olopade,et al.  Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. , 1999, Journal of the National Cancer Institute.

[3]  R. Croyle,et al.  Familial context of genetic testing for cancer susceptibility: moderating effect of siblings' test results on psychological distress one to two weeks after BRCA1 mutation testing. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[4]  J. Benkendorf,et al.  Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[5]  G. Lenoir,et al.  An update on DNA-based BRCA1/BRCA2 genetic counseling in hereditary breast cancer. , 1999, Cancer genetics and cytogenetics.

[6]  A. Cull,et al.  The impact of genetic counselling about breast cancer risk on women's risk perceptions and levels of distress , 1999, British Journal of Cancer.

[7]  Michael J. Watson,et al.  The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer , 1999, British Journal of Cancer.

[8]  D J Schaid,et al.  Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. , 1999, The New England journal of medicine.

[9]  H. Olsson.  Cancer risks in BRCA2 mutation carriers. , 1999, Journal of the National Cancer Institute.

[10]  C K Redmond,et al.  Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.

[11]  J. Passchier,et al.  Course of Distress Experienced by Persons at Risk for an Autosomal Dominant Inheritable Disorder Participating in a Predictive Testing Program: An Explorative Study , 1998, Psychosomatic medicine.

[12]  D. Schultz,et al.  An analysis of age and family history on outcome after breast-conservation treatment: the University of Pennsylvania experience. , 1998, The cancer journal from Scientific American.

[13]  B. Haffty,et al.  Local recurrence in the conservatively treated breast cancer patient: a correlation with age and family history. , 1998, The cancer journal from Scientific American.

[14]  R. Eeles,et al.  Family history of breast cancer: what do women understand and recall about their genetic risk? , 1998, Journal of medical genetics.

[15]  B. Ponder,et al.  Oral Contraceptives and the Risk of Hereditary Ovarian Cancer , 1998 .

[16]  Time elapsing from cancer diagnosis and anxiety in women attending cancer genetic clinics. , 1998, Oncology reports.

[17]  J. Manola,et al.  Family history and treatment outcome in young women after breast-conserving surgery and radiation therapy for early-stage breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  S. Narod,et al.  What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  J Chang-Claude,et al.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.

[20]  B. Peshkin,et al.  Psychological distress in women seeking genetic counseling for breast-ovarian cancer risk: The contributions of personality and appraisal , 1997, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[21]  W. Neufeld-Kaiser,et al.  Predisposition genetic testing for late-onset disorders in adults. A position paper of the National Society of Genetic Counselors. , 1997, JAMA.

[22]  P. Devilee,et al.  BRCA1 in the family: a case description of the psychological implications. , 1997, American journal of medical genetics.

[23]  P. Tonin,et al.  A descriptive study of BRCA1 testing and reactions to disclosure of test results , 1997, Cancer.

[24]  K M Kuntz,et al.  Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. , 1997, The New England journal of medicine.

[25]  P. Hartge,et al.  The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. , 1997, The New England journal of medicine.

[26]  B. Wilfond,et al.  Genetic Testing for Susceptibility to Adult-Onset Cancer: The Process and Content of Informed Consent , 1997 .

[27]  K Offit,et al.  Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. , 1997, JAMA.

[28]  E. Thomson,et al.  Recommendations for Follow-up Care of Individuals With an Inherited Predisposition to Cancer: I. Hereditary Nonpolyposis Colon Cancer , 1997 .

[29]  J. Benkendorf,et al.  Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. , 1997, Journal of the National Cancer Institute.

[30]  J. E. Nash,et al.  Psychological responses to BRCA1 mutation testing: preliminary findings. , 1997, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[31]  K. Schneider,et al.  Genetic counseling for BRCA1/BRCA2 testing. , 1997, Genetic testing.

[32]  R. Eeles,et al.  Familial breast cancer: a controlled study of risk perception, psychological morbidity and health beliefs in women attending for genetic counselling. , 1996, British Journal of Cancer.

[33]  B. Trock,et al.  BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. , 1996, JAMA.

[34]  M. Skolnick,et al.  Statement of the American Society of Clinical Oncology : Genetic testing for cancer susceptibility. Commentaries , 1996 .

[35]  M D Schwartz,et al.  Coping disposition, perceived risk, and psychological distress among women at increased risk for ovarian cancer. , 1995, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[36]  J. Struewing,et al.  Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[37]  D. C. Howell,et al.  Predictors of cancer progression in young adult men and women: avoidance, intrusive thoughts, and psychological symptoms. , 1994, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[38]  H. Lynch,et al.  Psychological aspects of monitoring high risk women for breast cancer , 1994, Cancer.

[39]  M. Daly,et al.  Attitudes about genetic testing for breast-ovarian cancer susceptibility. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  D. Easton,et al.  Risks of cancer in BRCA1-mutation carriers , 1994, The Lancet.

[41]  Lloyd M. Smith,et al.  Statement on use of DNA testing for presymptomatic identification of cancer risk. National Advisory Council for Human Genome Research. , 1994, JAMA.

[42]  F. Collins,et al.  Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. , 1993, JAMA.

[43]  K. Rickels,et al.  Psychiatric illness in family practice. , 1980, The Journal of clinical psychiatry.

[44]  M. Horowitz,et al.  Impact of Event Scale: A Measure of Subjective Stress , 1979, Psychosomatic medicine.

[45]  L. Covi,et al.  The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. , 1974, Behavioral science.